These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2534445)

  • 1. Plasmin-a2-plasmin inhibitor complex in plasma of patients with thromboembolic diseases.
    Wada K; Takahashi H; Tatewaki W; Takizawa S; Shibata A
    Thromb Res; 1989 Dec; 56(6):661-5. PubMed ID: 2534445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
    Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
    Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis in patients with diabetic nephropathy determined by plasmin-alpha 2 plasmin inhibitor complexes in plasma.
    Yagame M; Eguchi K; Suzuki D; Machimura H; Takeda H; Inoue W; Tanaka K; Kaneshige H; Nomoto Y; Sakai H
    J Diabet Complications; 1990; 4(4):175-8. PubMed ID: 2151230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fibrinolytic therapy by measuring cross-linked fibrin derivatives and plasmin-alpha 2-plasmin inhibitor complex in plasma.
    Takahashi H; Takizawa S; Hanano M; Tatewaki W; Nagasaki Y; Sasagawa Y; Shibata A
    Tohoku J Exp Med; 1987 Dec; 153(4):295-302. PubMed ID: 2964745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of fibrinolytic markers and venous thromboembolism.
    Folsom AR; Cushman M; Heckbert SR; Rosamond WD; Aleksic N
    J Clin Epidemiol; 2003 Jun; 56(6):598-603. PubMed ID: 12873656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis?
    Oshima S; Uchida K; Yasu T; Uno K; Nonogi H; Haze K
    Arterioscler Thromb; 1991; 11(6):1772-7. PubMed ID: 1834167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus.
    Kawakami M; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishii H; Kazama M; Kawagoe M; Nakamura H
    J Rheumatol; 1992 Nov; 19(11):1704-9. PubMed ID: 1337109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and clinical application of a new ELISA assay to determine plasmin-alpha2-antiplasmin complexes in plasma.
    Montes R; Páramo JA; Anglès-Cano E; Rocha E
    Br J Haematol; 1996 Mar; 92(4):979-85. PubMed ID: 8616097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
    Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma.
    Takeda S; Katoh H; Takaki A; Okamoto K; Ohsato K
    Thromb Res; 1990 Jan; 57(2):289-300. PubMed ID: 2156347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy.
    Uchiyama T; Matsumoto M; Kobayashi N
    Thromb Res; 1990 Sep; 59(6):955-65. PubMed ID: 2148228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin-alpha 2-plasmin inhibitor complex and alpha 2-plasmin inhibitor in chronic subdural hematoma.
    Saito K; Ito H; Hasegawa T; Yamamoto S
    J Neurosurg; 1989 Jan; 70(1):68-72. PubMed ID: 2521247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.
    Inman RD; Harpel PC
    J Rheumatol; 1986 Jun; 13(3):535-7. PubMed ID: 2942685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of age on in vitro plasmin generation in the presence of fibrin monomer.
    Parmar N; Mitchell LG; Berry LR; Andrew M; Chan AK
    Acta Haematol; 2006; 115(3-4):141-51. PubMed ID: 16549888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on fibrinolysis; plasminogen, plasmin, and antiplasmin content of human blood.
    MACFARLANE RG; PILLING J
    Lancet; 1946 Oct; 2(6425):562-5. PubMed ID: 21001709
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of fibrinogenolysis in patients with closed head injury.
    Kushimoto S; Shibata Y; Yamamoto Y
    J Neurotrauma; 2003 Apr; 20(4):357-63. PubMed ID: 12866815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.